GexVal
Developer of a drug designed to focus on orphan and intractable diseases. The company develops compounds for the treatment of rare diseases in the psychiatry and neurology areas and for pulmonary arte...
Valuation
$16.4M
Market implied
Share Price
N/A
Total Raised
$15.4M
Last Round
N/A